Sunday November 8, 2009 5:10 AM ET
SmartMoney
Share Price ($): 
12.07
Price Change: 
0.04 (0.33%)
Last 10 Quotes
What is this?
AMLN 
(Amylin Pharmaceuticals Inc.)
Exchange: NASD     Industry: Biotechnology
Last Trade 3:59 PM ET 11/6/2009
Click Here Click Here
Volume:1,871,057
Day's Low:$11.90
52-wk Low:$5.50
Previous Close:$12.03
Dividend:$0.00
Market Cap: 1,704,000
Avg Volume: 3,197,000
Day's High:$12.12
52-wk High:$15.69
Open Price:$11.90
Yield: 0.00%
P/E (Forward):NA
Chart for AMLN
After-Hours Trading:
Last Trade:4:12 PM
Price:12.02
Volume:200
Breaking News
4:48 PM  11/2/2009   UPDATE:FDA Approves New Byetta Label Amid Renal-Failure Reports
8:19 AM  10/29/2009   UPDATE: Roche's New Diabetes Drug Works Better Than Byetta
4:48 AM  10/29/2009   Roche: New Diabetes Drug Works Better Than Byetta - Study
9:58 PM  10/19/2009   Galleon Holdings Include OSI Pharmaceuticals, Huron Consulting
5:06 PM  10/19/2009   2ND UPDATE:Galleon Holdings Include OSI Pharma,Huron Consulting
4:02 PM  10/19/2009   UPDATE: Galleon Holdings Include OSI Pharma, Huron Consulting
Stories & Blogs
11/2/2009  Stocks in the Spotlight Monday
11/2/2009  Monday's biggest gaining and declining stocks
11/2/2009  Human Genome, Vertex, Amylin in play
10/30/2009  Drug stocks slip; Ipsen gains for second day
10/19/2009  OSI, Huron Among Galleon Holdings
10/5/2009  Fund Doubles Amylin Stake
9/25/2009  Another Diabetes Drug is Linked to Pancreas Inflammation
Earnings & Forecast
Most Recent Quarter ($)Same Quarter Last Year ($)% Change
EPS, Pro Forma -0.19 -0.46 58.70
EPS, GAAP -0.19 -0.57 66.67
Consensus Estimate -0.30 -0.51 41.18
Trailing 12 MonthsYear-Earlier Period% Change
EPS, Pro Forma -1.25 -1.80 30.56
EPS, GAAP -2.11 -2.12 0.47
Consensus Estimate -1.51 NA NA
Key Statistics
AMLNIndustry Average
P/E (TTM) -5.72 185.00
P/E (Forward)NA -21.30
PEG RatioNA -1.08
Price/Sales 2.06 4.67
Beta 1.55 1.72
Advertisements
View Overview for: